Force Therapeutics Enters AAOS PROMs Vendor Program
Force Therapeutics is thrilled to announce its participation in the American Academy of Orthopaedic Surgeons (AAOS) PROMs Vendor Program. This program aims to improve the collection and understanding of patient outcomes data in orthopaedic care.
Supporting Orthopaedic Surgeons in Patient Engagement
The addition of Force Therapeutics to the AAOS program showcases the company’s commitment to empowering healthcare providers. Their comprehensive patient-reported outcome measures (PROMs) solution aims to make it easier for clinicians to gather and analyze patient data effectively.
Significance of the PROMs Vendor Program
By being part of the AAOS PROMs Vendor Program, Force Therapeutics is at the forefront of enhancing quality care. This recognition illustrates their ability to support physicians with efficient processes for implementing PROMs directly at the point of care.
A Commitment to Quality and Value-Based Care
Bronwyn Spira, CEO of Force Therapeutics, expressed pride in this endorsement, emphasizing the importance of simplifying outcomes reporting. As the healthcare landscape shifts towards value-based care, Force Therapeutics focuses on improving clinical decisions and patient engagement through their innovative solutions.
Understanding the Selection Criteria
Participants in the AAOS PROMs Vendor Program are chosen based on criteria that assess their capability in collecting and submitting patient-reported outcomes. These standards create a collaborative environment that helps healthcare professionals in realizing better patient care outcomes.
The Voice of Experience
Dr. Kurt P. Spindler, chair of the AAOS PROMs workgroup, highlighted the vital role that technology vendors play in alleviating the challenges of collecting patient-reported outcome data. He expressed enthusiasm about welcoming Force Therapeutics into the select group of AAOS PROMs Vendors, looking forward to supporting AAOS members in the process of PROMs integration.
About Force Therapeutics
Force Therapeutics is a leading force in patient engagement and care coordination. Their software solutions enhance patient involvement in their healthcare journey, particularly during specialty procedures. By providing validated remote patient care tools, they empower healthcare providers to deliver exceptional value and improve clinical workflows.
About AAOS
The American Academy of Orthopaedic Surgeons is the largest association focused on musculoskeletal health, comprising over 39,000 members. AAOS positions itself as a trusted leader in advancing the field of orthopaedics. Their commitment to education ensures that health professionals are equipped with the resources they need to treat patients effectively.
Frequently Asked Questions
1. What is the AAOS PROMs Vendor Program?
The AAOS PROMs Vendor Program is designed to assist orthopaedic surgeons in collecting patient-reported outcomes effectively to improve care quality.
2. How does Force Therapeutics support patient engagement?
Force Therapeutics enhances patient engagement through validated remote care solutions that streamline data collection and clinical workflows.
3. Who selects the vendors for the AAOS program?
Vendors are selected based on their ability to collect and submit patient-reported outcomes data, track records, and other criteria defined by AAOS.
4. What are patient-reported outcome measures (PROMs)?
PROMs are tools used to collect information directly from patients regarding their health status, quality of life, and treatment outcomes.
5. Why is value-based care important?
Value-based care emphasizes quality over quantity, ensuring that patients receive better outcomes at lower costs, which is crucial for sustainable healthcare.
